|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
University of Alberta Canadian Diabetes Association Heart and Stroke Foundation of Ontario College and Association of Registered Nurses of Alberta Alberta Health & Wellness Medicine Shoppe of Canada Canadian Council of Cardiovascular Nurses MED Institute, Incorporated Capital Health, Canada Alberta Heritage Foundation for Medical Research Alberta Medical Association Merck Frosst Canada Ltd. |
|---|---|
| Information provided by: | University of Alberta |
| ClinicalTrials.gov Identifier: | NCT00374270 |
Purpose
About 22% of Canadians have high blood pressure, or hypertension. However, studies have shown that only 1 out of 5 people with hypertension have their blood pressure controlled.
Diabetes is also an important risk factor for heart disease and stroke. About half of people with diabetes also have hypertension - a deadly combination. Studies have shown that only about 1 in 10 people with diabetes have their blood pressure controlled adequately - clearly something needs to be done to improve this.
Heart disease, stroke, hypertension, and diabetes are conditions that occur in the community, so we need to explore innovative solutions that will work in the community. Pharmacists are well-placed in the community to help identify people with diabetes and hypertension. This has worked very well in previous studies in patients with high cholesterol levels. Pharmacists and nurses have complementary skills which, when working as a team, may help identify and better manage hypertension in people with diabetes.
Our main objective is to test whether a community pharmacist and nurse team can improve blood pressure control in people with diabetes and hypertension.
| Condition | Intervention | Phase |
|---|---|---|
|
Hypertension Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 |
Behavioral: Lifestyle Counselling; Opinion Leader Influence Statements |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Single Blind (Investigator), Active Control, Single Group Assignment |
| Official Title: | Improving Blood Pressure Management in Patients With Diabetes: SCRIP-HTN |
| Enrollment: | 227 |
| Study Start Date: | May 2005 |
| Study Completion Date: | May 2007 |
Show Detailed Description Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
The following patients will be eligible for study participation:
Exclusion Criteria:
Patients will be excluded from the study if they:
Subjects will be recruited whether or not they are receiving antihypertensive therapy.
Contacts and Locations| Canada, Alberta | |
| University of Alberta | |
| Edmonton, Alberta, Canada, T6G 2C8 | |
| Principal Investigator: | Ross T Tsuyuki, PharmD, MSc | University of Alberta |
More Information
| Responsible Party: | University of Alberta ( Dr. Ross Tsuyuki ) |
| Study ID Numbers: | EPICORE-GG5130000107 |
| Study First Received: | September 8, 2006 |
| Last Updated: | December 7, 2007 |
| ClinicalTrials.gov Identifier: | NCT00374270 |
| Health Authority: | Canada: Ethics Review Committee |
|
Diabetes (type I and type II) |
|
Autoimmune Diseases Metabolic Diseases Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Vascular Diseases Diabetes Mellitus |
Endocrine System Diseases Endocrinopathy Metabolic disorder Glucose Metabolism Disorders Hypertension |
|
Immune System Diseases Cardiovascular Diseases |
